Research Paper Volume 11, Issue 23 pp 10883—10901

Clinical and transcriptional signatures of human CD204 reveal an applicable marker for the protumor phenotype of tumor-associated macrophages in breast cancer

Figure 2. Survival analysis of breast cancer with high and low CD204 expression statuses among untreated patients, including all cases of breast cancer (AC), luminal A (DF), luminal B (GI), HER2-positive (J, K), and basal-like (LN) subtype.